Analyst firms · Stephens · PNTG
Stephens PNTG price target and rating history
The Pennant Group Inc. (PNTG) · Health Care
Stephens rates The Pennant Group Inc. (PNTG) Overweight with a $18 price target, as of its latest action on Jan 5, 2024. It has published 3 rating actions on PNTG since March 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Overweight
- Price target
- $18
- Median target, all firms
- Too few
- Actions on PNTG
- 3
Stephens price target on PNTG
Every Stephens rating on PNTG
- Jan 5, 2024
- Jun 21, 2022
- Mar 2, 2022
How other firms rate PNTG
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| William Blair | Outperform | Dec 8, 2025 | |
| Truist Securities | Buy | $34 | Dec 2, 2025 |
| Wells Fargo | Overweight | $31 | Nov 18, 2025 |
Questions about Stephens and PNTG
- What is Stephens's price target for PNTG?
- Stephens's latest stated price target for The Pennant Group Inc. (PNTG) is $18, from its action on Jan 5, 2024.
- What is Stephens's rating on PNTG?
- Stephens rates PNTG Overweight, a bullish rating, as of Jan 5, 2024.
- When did Stephens last change its view on PNTG?
- On Jan 5, 2024, Stephens upgrades to Overweight from Equal-Weight, price target $14 to $18.
More PNTG rating histories
All Stephens ratingsPNTG news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.